Thymosin beta 4 half-life is short in plasma, often measured in minutes. Learn what research says about TB-500 dosing, detection, and clearance.
Thymosin beta 4, commonly sold as TB-500, has a short plasma half-life that is generally reported in the range of about one to three hours, depending on species, dose, and route of administration. That means the peptide clears from the bloodstream quickly, even though tissue-binding activity can persist much longer. Almost all of the hard numbers come from animal and laboratory studies, because thymosin beta 4 is not approved by the FDA for human use in the United States.
What "Half-Life" Actually Measures
Half-life is the time it takes for half of a substance in the bloodstream to be cleared or broken down. It is a pharmacokinetic measurement, not a measure of how long a peptide's effects last.
A peptide with a two-hour half-life is mostly gone from plasma after roughly eight to ten hours, which is about four to five half-lives. Thymosin beta 4 binds to actin and interacts with tissue, so cellular activity can continue after blood levels fall below detection.
Two different numbers get mixed up constantly: plasma half-life and detection window. Anti-doping labs test urine and blood, not plasma kinetics, and that is why an athlete can test positive long after the pharmacokinetic curve has flattened.
Reported Thymosin Beta 4 Half-Life by Route
How a peptide enters the body changes how fast it leaves. Intravenous doses reach peak concentration almost immediately, while subcutaneous and intramuscular injections absorb more slowly and therefore appear to last longer.
| Route | Commonly cited plasma half-life | What it means |
|---|---|---|
| Intravenous (IV) | About 1–2 hours | Fast peak, fast renal and enzymatic clearance |
| Subcutaneous (SubQ) | About 2–4 hours, apparent | Slow absorption keeps blood levels detectable longer |
| Intramuscular (IM) | About 2–4 hours, apparent | Similar to SubQ; influenced by blood flow at the site |
Values like these are estimates drawn from small animal studies and modeling. Human pharmacokinetic data for thymosin beta 4 remains scarce.
How Long Is Thymosin Beta 4 Detectable?
Detection windows run much longer than half-lives. Anti-doping authorities have reported TB-500 metabolites in urine for days to weeks after a single dose, and longer with repeated use.
The gap exists because half-life describes plasma clearance while detection depends on metabolites retained in tissue and on excretion timing. A substance with a two-hour half-life can still trigger a positive test a week later.
People researching peptide clearance often look at thymosin alpha 1 half-life as a comparison point, since the two thymosins are frequently confused. Thymosin alpha 1 is a different 28-amino-acid peptide with its own kinetics and a very different regulatory history.
Thymosin Beta 4 vs. Other Research Peptides
Half-life ranges enormously across this category, from minutes to more than a week. The table below summarizes the figures most often cited in the literature and in vendor documentation.
| Peptide | Commonly cited half-life | Key note |
|---|---|---|
| Thymosin beta 4 (TB-500) | 1–3 hours | Short plasma life, longer tissue activity |
| Thymosin alpha 1 | About 2 hours | Distinct peptide; approved in some countries |
| AOD 9604 | About 30 minutes | hGH fragment with a very short window |
| CJC-1295 with DAC | 6–8 days | Drug affinity complex extends circulation |
| CJC-1295 without DAC | About 30 minutes | Rapid enzymatic clearance |
| Melanotan II | 1–2 hours | Not approved; documented safety concerns |
| Selank | Under 1 hour | Fast breakdown by peptidases |
| Cagrilintide | About 7–8 days | Long-acting amylin analog |
That spread explains why dosing schedules vary so much between compounds. A peptide with a week-long half-life may be studied with once-weekly administration, while a peptide cleared in 30 minutes may need multiple daily doses or a slow-release formulation.
Chemical modifications matter as much as the parent molecule. Attaching a fatty acid chain, adding a PEG group, or using a drug affinity complex can stretch circulation time dramatically. The cjc-1295 half-life is measured in days, while the cjc 1295 no dac half-life drops back to roughly half an hour.
Other peptides follow the same rule. The melanotan ii half life is usually cited at one to two hours, and the aod 9604 half-life is typically reported at around 30 minutes.
Why Reported Numbers Don't Match
- Species: rat and rabbit data dominate, while human data is limited.
- Assay method: ELISA, LC-MS/MS, and radiolabeled tracers produce different results.
- Dose size: large doses can saturate the pathways responsible for clearance.
- Injection site: blood flow at the site changes absorption speed.
- Formulation: a simple reconstituted solution behaves differently than a controlled-release depot.
Because of these variables, no single official figure exists. Published numbers should be read as ranges rather than fixed constants.
Safety and Legal Status
Thymosin beta 4 is not FDA-approved for human use in the United States, and it is prohibited in sport by the World Anti-Doping Agency. Products sold online as TB-500 are unregulated, so purity, actual peptide content, and sterility are not guaranteed.
Anyone considering a research peptide should speak with a licensed healthcare professional before using it. Half-life data informs dosing schedules, but it says nothing about whether a substance is safe.
Key Takeaways
- Thymosin beta 4 has a short plasma half-life, typically reported at one to three hours.
- Route of administration changes the apparent half-life more than dose does.
- Detectability lasts far longer than the half-life, often days to weeks.
- Tissue-level activity can outlast measurable blood concentrations.
- Half-life is a clearance measurement, not a measure of how long effects persist.
Frequently Asked Questions
What is the half-life of thymosin beta 4?
Published estimates place the plasma half-life of thymosin beta 4 at roughly one to three hours, with intravenous doses clearing fastest and subcutaneous doses appearing to last slightly longer. These figures come mainly from animal and laboratory research rather than human trials. Half-life describes plasma clearance, not how long the peptide's biological effects last.
How long does TB-500 stay in your system?
Plasma levels of TB-500 fall below detection within hours, but anti-doping testing can identify TB-500 metabolites in urine for days to weeks after a dose. Repeated use tends to extend that detection window. Half-life and detection window are separate measurements and should not be used interchangeably.
Is thymosin beta 4 approved by the FDA?
No. Thymosin beta 4 is not FDA-approved for human use in the United States, and products sold as TB-500 are unregulated. It is also banned by the World Anti-Doping Agency. Anyone with questions about peptide use should consult a licensed healthcare professional.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.